Animal Model Market Forecast 2025-2034: Analysing Major Trends, Opportunities, and Growth Drivers

What combination of drivers is leading to accelerated growth in the animal model market?
The expansion of the animal model market is predicted to be accelerated by rising investment in pharmaceutical research and development activities. The procedure of pharmaceutical research and development is intricate, merging scientific knowledge and innovation to promote medical progress. The emergence of innovative therapies and the pursuit of solutions for complex diseases, coupled with the stimulation of scientific interest and commercial possibilities, fuels the research and development processes in the healthcare sector. Animal models are integral to pharmaceutical research and development as they allow for predictions of drug efficacy, safety, and toxicity. They offer vital insights into biological processes and assist in creating new treatments by replicating human physiological reactions and disease progression in controlled environments. For example, the European Federation of Pharmaceutical Industries and Associations, a Belgium-based trade and lobbying body, reported in June 2023 that pharmaceutical research and development spending in Europe was €44,500 ($47,999) in 2022, an increase from €42,533 million ($45,877 million) in 2021. Consequently, the growth in pharmaceutical research and development investment is pushing the animal model market forward.

Get Your Animal Model Market Report Here:
https://www.thebusinessresearchcompany.com/report/animal-model-global-market-report

What is the projected compound annual growth rate (CAGR) of the animal model market from 2025 to 2034, and what factors influence it?
Recent years have witnessed significant growth in the animal model market size. The market, pegged at $1.92 billion in 2024, is expected to rise to $2.09 billion in 2025, indicating a compound annual growth rate (CAGR) of 9.0%. Factors contributing to the growth during the historical period include increased use of animal models for biomedical research, a surge in expenditure and large investments in drug discovery and development, amplified emphasis on precision medicine, and the wide-ranging use of animal models in the healthcare sector.

The market for animal models is predicted to experience substantial growth in the upcoming years, with its value soaring to $2.92 billion by 2029, following a compound annual growth rate (CAGR) of 8.8%. This progression during the forecast period can be credited to advancements in genetic engineering, a heightened emphasis on personalized medicine, a growing incidence of chronic illnesses, an increasing demand for effective vaccines and therapies, as well as heightened investment in biomedical research. The forecast period also sees a surge in trends like increased need for animal models in pharmaceutical discovery and development, growing rates of chronic illnesses, similarities in physiology between humans and animals leading to reduced drug development timelines, increased use of personalized medicine fueling the need for humanized mice models, and market growth acceleration due to the growing acceptance of animal models for biomedical research.

Get Your Free Sample Now - Explore Exclusive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=15510&type=smp

How are the latest trends influencing the growth of the animal model market?
Leading companies within the animal model market are concentrating on the creation of innovative products, such as triple-immunodeficient animal models. They do this to improve the precision and dependability of preclinical trials, aid in sophisticated biomedical research, and aid in the creation of new treatments for complex human diseases. Triple-immunodeficient animal models - primarily mice - are designed animals that are without three crucial immune system components. These models are vital for biomedical research, predominantly for researching human diseases and designing new treatments. For example, in January 2024, the US-based pharmaceutical firm Charles River Laboratories International, Inc. released NCG mouse strains, which are a triple-immunodeficient mouse model utilized in oncology research. NCG mice, which lack functional/mature T, B, and NK cells and portray a reduction in macrophage and dendritic cell function, serve as hosts to xenograft cells, tissues, and components of the human immune system. These mice are suitable for studies in fields such as oncology, immunology, tumor biology, infectious diseases, graft-versus-host disease (GvHD), diabetes, regenerative medicine, hematopoiesis, and tissue transplant. Moreover, they can generate humanized mice by grafting PBMCs or CD34+ stem cells, thus closely resembling the human immune system.

What are the major segments of the animal model market and their role in driving growth?
The animal model market covered in this report is segmented -

1) By Animal Type: Mice, Rat, Guinea Pigs, Rabbits, Hamsters, Other Animal Types
2) By Technology: Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR), Embryonic Stem Cell Injection, Nuclear Transfer, Other Technologies
3) By Application: Drug Discovery And Development, Basic Research, Other Applications
4) By End User: Research Institutes, Educational Institutes, Pharmaceutical Companies, Contract Research Organizations

Subsegments:
1) By Mice: inbred* Mice, Outbred Mice, Knockout Mice, Transgenic Mice
2) By Rat: inbred* Rats, Outbred Rats, Transgenic Rats, Knockout Rats
3) By Guinea Pigs: Standard Guinea Pigs, Immunodeficient Guinea Pigs
4) By Rabbits: New Zealand White Rabbits, Dutch Belted Rabbits, Other Rabbit Breeds
5) By Hamsters: Syrian Hamsters, Chinese Hamsters
6) By Other Animal Types: Non-Human Primates (Monkeys, Chimpanzees), Dogs, Pigs, Sheep, Ferrets, Other Small Animals (Ferrets, Gerbils)

Unlock Exclusive Market Insights - Purchase Your Research Report Now!
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=15510

Which regions are key players in the growth of the animal model market?
North America was the largest region in the animal model market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the animal model market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Who are the key firms paving the way for growth in the animal model market?
Major companies operating in the animal model market are Eurofins Scientific SE, Charles River Laboratories International Inc., Pharmaron Beijing Co Ltd., Inotiv Inc., Biocytogen, Taconic Biosciences Incorporation, Cyagen Biosciences, Trans Genic Incorporation, Crown Bioscience Incorporation, Harbor BioMed, PharmaLegacy, PsychoGenics, Biomere Biomedical Research Models Inc., Genoway S.A, Alloy Therapeutics, Janvier Labs, Hera Biolabs, Ozgene Pty Ltd., Transposagen Biopharmaceuticals Inc., KMT Hepatech Inc., AniLocus Inc., BioXpert, Harlan Sprague Dawley Inc.

Customize Your Report - Get Tailored Market Insights!
https://www.thebusinessresearchcompany.com/customise?id=15510&type=smp

What Is Covered In The Animal Model Global Market Report?

•Market Size Forecast: Examine the animal model market size across key regions, countries, product categories, and applications.
•Segmentation Insights: Identify and classify subsegments within the animal model market for a structured understanding.
•Key Players Overview: Analyze major players in the animal model market, including their market value, share, and competitive positioning.
•Growth Trends Exploration: Assess individual growth patterns and future opportunities in the animal model market.
•Segment Contributions: Evaluate how different segments drive overall growth in the animal model market.
•Growth Factors: Highlight key drivers and opportunities influencing the expansion of the animal model market.
•Industry Challenges: Identify potential risks and obstacles affecting the animal model market.
•Competitive Landscape: Review strategic developments in the animal model market, including expansions, agreements, and new product launches.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.